HHV-6-related acute liver failure in two immunocompetent adults: Favourable outcome after liver transplantation and/or ganciclovir therapy

Journal of Internal Medicine

Volumn 258, Issue 6, 2005, Pages 573-578

  Cacheux, W ^a   Carbonell, N ^a   Rosmorduc, O ^a   Wendum, D ^a   Paye, F ^a   Poupon, R ^a   Chazouilleres O ^a   Gozlan, J ^a,b  

^a HÔPITAL SAINT ANTOINE   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Acute liver failure; Ganciclovir; Human herpesvirus 6; Liver transplantation; Real time polymerase chain reaction

Indexed keywords

ACICLOVIR; GANCICLOVIR; METHYLPREDNISOLONE SODIUM SUCCINATE; VALGANCICLOVIR; VIRUS DNA;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; FEMALE; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN TISSUE; IMMUNOCOMPETENCE; LABORATORY TEST; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; VIRUS LOAD;

ADMINISTRATION, ORAL; ADULT; ANTIVIRAL AGENTS; FEMALE; GANCICLOVIR; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOCOMPETENCE; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; ROSEOLOVIRUS INFECTIONS; TREATMENT OUTCOME;

EID: 28244470759     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2005.01567.x     Document Type: Article

References (24)

1. Salahuddin SZ, Ablashi DV, Markham PD et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986; 234: 596-601.
2. Yamanishi K, Okuno T, Shiraki K et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988; 1: 1065-7.
3. Caserta MT, Mock DJ, Dewhurst S. Human herpesvirus 6. Clin Infect Dis 2001; 33: 829-33.
4. Asano Y, Yoshikawa T, Suga S, Yazaki T, Kondo K, Yamanishi K. Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection. Lancet 1990; 335: 862-3.
5. Dubedat S, Kappagoda N. Hepatitis due to human herpesvirus-6. Lancet 1989; 2: 1463-4.
6. Mendel I, de Matteis M, Bertin C et al. Fulminant hepatitis in neonates with human herpesvirus 6 infection. Pediatr Infect Dis J 1995; 14: 993-7.
7. Sobue R, Miyazaki H, Okamoto M, Hirano M et al. Fulminant hepatitis in primary human herpesvirus-6 infection. N Engl J Med 1991; 324: 1290.
8. Tajiri H, Nose O, Baba K, Okada S. Human herpesvirus-6 infection with liver injury in neonatal hepatitis. Lancet 1990; 335: 863.
9. Harma M, Hockerstedt K, Lautenschlager I. Human herpesvirus-6 and acute liver failure. Transplantation 2003; 76: 536-9.
10. Ishikawa K, Hasegawa K, Naritomi T et al. Prevalence of herpesviridae and hepatitis virus sequences in the livers of patients with fulminant hepatitis of unknown etiology in Japan. J Gastroenterol 2002; 37: 523-30.
11. Mason A, Sallie R, Perrillo R et al. Prevalence of herpesviridae and hepatitis B virus DNA in the liver of patients with non-A, non-B fulminant hepatic failure. Hepatology 1996; 24: 1361-5.
12. Najioullah F, Thouvenot D, Lina B. Development of a real-time PCR procedure including an internal control for the measurement of HCMV viral load. J Virol Methods 2001; 92: 55-64.
13. Collot S, Petit B, Bordessoule D et al. Real-time PCR for quantification of human herpesvirus 6 DNA from lymph nodes and saliva. J Clin Microbiol 2002; 40: 2445-51.
14. Lallemand F, Desire N, Rozenbaum W, Nicolas JC, Marechal V. Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay. J Clin Microbiol 2000; 38: 1404-8.
15. Fredericks DN, Relman DA. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev 1996; 9: 18-33.
16. Cermelli C, Concari M, Carubbi F et al. Growth of human herpesvirus 6 in HEPG2 cells. Virus Res 1996; 45: 75-85.
17. Inagi R, Guntapong R, Nakao M et al. Human herpesvirus 6 induces IL-8 gene expression in human hepatoma cell line, Hep G2. J Med Virol 1996; 49: 34-40.
18. Ozaki Y, Tajiri H, Tanaka-Taya K et al. Frequent detection of the human herpesvirus 6-specific genomes in the livers of children with various liver diseases. J Clin Microbiol 2001; 39: 2137-73.
19. De Clercq E. Naesens L, De Bolle L, Schols D, Zhang Y, Neyts J. Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8. Rev Med Virol 2001; 11: 381-95.
20. Yoshida M, Yamada M, Tsukazaki T et al. Comparison of antiviral compounds against human herpesvirus 6 and 7. Antiviral Res 1998; 40: 73-84.
21. De Bolle L, Michel D, Mertens T et al. Role of the human herpesvirus 6 u69-encoded kinase in the phosphorylation of ganciclovir. Mol Pharmacol 2002; 62: 714-21.
22. Tokimasa S, Hara J, Osugi Y et al. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation. Bone Marrow Transplant 2002; 29: 595-8.
23. Yoshida H, Matsunaga K, Ueda T et al. Human herpesvirus 6 meningoencephalitis successfully treated with ganciclovir in a patient who underwent allogeneic bone marrow transplantation from an HLA-identical sibling. Int J Hematol 2002; 75: 421-42.
24. Zerr DM, Gupta D, Huang ML, Carter R, Corey L. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 309-17.